CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.01 $49.16 (-3.17%) -3.89% +6.86% -10.75
17/03/2014 TGD.US 1 out of 5 Outperform 5Y $1.70 $1.17 (-6.40%) -29.32% +6.86% -36.19
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.20 (-4.76%) -35.05% +6.86% -41.92
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $27.30 (-4.55%) -37.36% +6.86% -44.22
17/03/2014 AEM.US 4 out of 5 Outperform 5Y $34.20 $25.26 (-10.04%) -25.92% +6.86% -32.78
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $1.47 (-11.21%) -76.45% +6.86% -83.32
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.12 $19.27 (-10.46%) -30.87% +6.86% -37.73
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $297.38 (+1.11%) +65.29% +44.41% -20.88
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $3.19 (-8.07%) -47.71% +32.47% -80.18
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.85 (-8.55%) -10.96% +30.70% -41.67
11/02/2013 PAAS.US 4 out of 5 Outperform 5Y $16.32 $9.81 (-4.11%) -39.44% +30.70% -70.15
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $2.33 (-7.17%) -27.16% +31.91% -59.07
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.49 (-4.85%) -89.29% +31.91% -121.21
04/02/2013 SSRI.US 4 out of 5 Outperform 5Y $12.09 $4.88 (-6.51%) -58.73% +31.94% -90.66
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.60 $4.29 (-7.34%) -65.57% +31.94% -97.51
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.37 (-6.93%) -85.35% +32.97% -118.32
23/01/2013 NRT.US 4 out of 5 Outperform 1Y $21.76 $18.60 (-1.74%) -14.93% +32.99% -47.92
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $6.16 (-7.30%) +21.07% +32.99% -11.92
23/01/2013 POT.US 4 out of 5 Outperform 5Y $38.90 $33.72 (+0.45%) -13.28% +32.99% -46.27
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $1.97 (-12.28%) -81.11% +35.02% -116.13
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.